{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T22:55:03Z","timestamp":1762556103141,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002642","name":"Korea University","doi-asserted-by":"publisher","award":["K2225751"],"award-info":[{"award-number":["K2225751"]}],"id":[{"id":"10.13039\/501100002642","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jmii.2025.04.004","type":"journal-article","created":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T02:51:04Z","timestamp":1746499864000},"page":"564-571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Questioning the Addition of Fluoroquinolone on Mortality in Severe Community-Acquired Pneumonia: A multicenter study in Korea"],"prefix":"10.1016","volume":"58","author":[{"given":"Se Ju","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3618-174X","authenticated-orcid":false,"given":"Soyoon","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5263-5639","authenticated-orcid":false,"given":"Ji Hyun","family":"Yun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Chan Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min Joo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4666-0672","authenticated-orcid":false,"given":"Ki Tae","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won Suk","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeseul","family":"Na","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"So Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taehyen","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyeri","family":"Seok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bongyoung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2025.04.004_bib1","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1001\/jama.2024.14796","article-title":"Community-acquired pneumonia: a review","volume":"332","author":"Vaughn","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.jmii.2025.04.004_bib2","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1097\/01.CCM.0000162381.24074.D7","article-title":"Severe community-acquired pneumonia as a cause of severe sepsis: data from the PROWESS study","volume":"33","author":"Laterre","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jmii.2025.04.004_bib3","first-page":"531","article-title":"Community-acquired pneumonia as an emergency condition","volume":"24","author":"Cill\u00f3niz","year":"2018","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.jmii.2025.04.004_bib4","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12879-018-3098-5","article-title":"Effects of age, comorbidity and adherence to current antimicrobial guidelines on mortality in hospitalized elderly patients with community-acquired pneumonia","volume":"18","author":"Han","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jmii.2025.04.004_bib5","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/MCP.0000000000000760","article-title":"New guidelines for severe community-acquired pneumonia","volume":"27","author":"Martin-Loeches","year":"2021","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.jmii.2025.04.004_bib6","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/490346","article-title":"Overview of community-acquired pneumonia and the role of inflammatory mechanisms in the immunopathogenesis of severe pneumococcal disease","volume":"2013","author":"Steel","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jmii.2025.04.004_bib7","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3947\/ic.2018.50.2.160","article-title":"Guideline for antibiotic Use in adults with community-acquired pneumonia","volume":"50","author":"Lee","year":"2018","journal-title":"Infect Chemother"},{"key":"10.1016\/j.jmii.2025.04.004_bib8","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American thoracic society and infectious diseases society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jmii.2025.04.004_bib9","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/00325481.2024.2347830","article-title":"Is the fluoroquinolone combination necessary for empirical antibiotic regimen in severe community-acquired pneumonia?","volume":"136","author":"Oh","year":"2024","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.jmii.2025.04.004_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90692-8","article-title":"The association between fluoroquinolones and aortic dissection and aortic aneurysms: a systematic review and meta-analysis","volume":"11","author":"Wee","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jmii.2025.04.004_bib11","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10096-007-0307-3","article-title":"Monotherapy versus combination antibiotic therapy for patients with bacteremic Streptococcus pneumoniae community-acquired pneumonia","volume":"26","author":"Chokshi","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2025.04.004_bib12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10096-021-04378-0","article-title":"Impact on in-hospital mortality of ceftaroline versus standard of care in community-acquired pneumonia: a propensity-matched analysis","volume":"41","author":"Cilloniz","year":"2022","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2025.04.004_bib13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.resinv.2015.05.003","article-title":"Update on the combination effect of macrolide antibiotics in community-acquired pneumonia","volume":"53","author":"Emmet O'Brien","year":"2015","journal-title":"Respir Investig"},{"key":"10.1016\/j.jmii.2025.04.004_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2023.106905","article-title":"Respiratory fluoroquinolone monotherapy vs. \u03b2-lactam plus macrolide combination therapy for hospitalized adults with community-acquired pneumonia: a systematic review and meta-analysis of randomized controlled trials","volume":"62","author":"Choi","year":"2023","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jmii.2025.04.004_bib15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/BF01966998","article-title":"Synergy and antagonism of combinations with quinolones","volume":"10","author":"Neu","year":"1991","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2025.04.004_bib16","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0732-8893(96)00174-5","article-title":"Timed killing kinetic studies of the interaction between ciprofloxacin and beta-lactams against gram-negative bacilli","volume":"26","author":"Pohlman","year":"1996","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jmii.2025.04.004_bib17","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/trstmh\/tru058","article-title":"The bacterial aetiology of adult community-acquired pneumonia in Asia: a systematic review","volume":"108","author":"Peto","year":"2014","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.jmii.2025.04.004_bib18","article-title":"Prevalence of atypical pathogens in patients with severe pneumonia: a systematic review and meta-analysis","volume":"13","author":"Wang","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/j.jmii.2025.04.004_bib19","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.3201\/eid2811.220273","article-title":"Severe pneumonia caused by corynebacterium striatum in adults, Seoul, South Korea, 2014-2019","volume":"28","author":"Lee","year":"2022","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jmii.2025.04.004_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/eci.12845","article-title":"The dilemma of monotherapy or combination therapy in community-acquired pneumonia","volume":"47","author":"Vardakas","year":"2017","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jmii.2025.04.004_bib21","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1086\/587519","article-title":"Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial","volume":"46","author":"Torres","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jmii.2025.04.004_bib22","doi-asserted-by":"crossref","first-page":"R8","DOI":"10.1186\/cc3934","article-title":"The impact of empiric antimicrobial therapy with a \u03b2-lactam and fluoroquinolone on mortality for patients hospitalized with severe pneumonia","volume":"10","author":"Mortensen","year":"2005","journal-title":"Crit Care"},{"key":"10.1016\/j.jmii.2025.04.004_bib23","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1001\/jamainternmed.2014.4887","article-title":"\u03b2-Lactam monotherapy vs \u03b2-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial","volume":"174","author":"Garin","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.jmii.2025.04.004_bib24","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/01.CCM.0000266755.75844.05","article-title":"Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock","volume":"35","author":"Rodr\u00edguez","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jmii.2025.04.004_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15030804","article-title":"Overview of side-effects of antibacterial fluoroquinolones: new drugs versus old drugs, a step forward in the safety profile?","volume":"15","author":"Rusu","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jmii.2025.04.004_bib26","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/bco2.286","article-title":"Fluoroquinolone resistance in urinary tract infections: epidemiology, mechanisms of action and management strategies","volume":"5","author":"Thompson","year":"2024","journal-title":"BJUI Compass"},{"key":"10.1016\/j.jmii.2025.04.004_bib27","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.3346\/jkms.2013.28.9.1276","article-title":"Mortality of community-acquired pneumonia in Korea: assessed with the pneumonia severity index and the CURB-65 score","volume":"28","author":"Kim","year":"2013","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jmii.2025.04.004_bib28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.rmed.2016.10.015","article-title":"Burden and risk factors of ambulatory or hospitalized CAP: a population based cohort study","volume":"121","author":"Kolditz","year":"2016","journal-title":"Respir Med"},{"key":"10.1016\/j.jmii.2025.04.004_bib29","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1136\/postgradmedj-2014-132802","article-title":"Short-term mortality of adult inpatients with community-acquired pneumonia: external validation of a modified CURB-65 score","volume":"91","author":"Pflug","year":"2015","journal-title":"Postgrad Med J"}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118225000866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118225000866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T22:51:18Z","timestamp":1762555878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118225000866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S1684118225000866"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2025.04.004","relation":{},"ISSN":["1684-1182"],"issn-type":[{"type":"print","value":"1684-1182"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Questioning the Addition of Fluoroquinolone on Mortality in Severe Community-Acquired Pneumonia: A multicenter study in Korea","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2025.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}